Yahoo
    NasdaqCM - Nasdaq Real Time Price USD

    Lunai Bioworks Inc. (LNAI)

    0.1648 0.0000 (0.00%)
    At close: October 29 at 4:00:01 PM EDT
    Loading Chart for LNAI
    Chart Range Bar
    Interval:
    In partnership with ChartIQ

    Recent News

    Lunai Bioworks (NASDAQ: LNAI) Expands Parkinson's Platform Through Exclusive Tanaist Agreement

    Lunai Bioworks (NASDAQ: LNAI) Expands Parkinson's Platform Through Exclusive Tanaist Agreement
    PR Newswire 1mo ago
    Lunai Bioworks (Nasdaq: LNAI) Demonstrates AI Chemical-Risk Screening for Generative AI

    Lunai Bioworks (Nasdaq: LNAI) Demonstrates AI Chemical-Risk Screening for Generative AI
    PR Newswire 1mo ago
    Lunai Bioworks (Nasdaq: LNAI) Names Six Broker-Dealers in Expanded Naked Short Selling Suit

    Lunai Bioworks (Nasdaq: LNAI) Names Six Broker-Dealers in Expanded Naked Short Selling Suit
    PR Newswire 2mo ago
    Lunai Bioworks (Nasdaq: LNAI) Signs Definitive Collaboration Agreement with BrainStorm Therapeutics; Initial Parkinson's Disease Data Readout Targeted for First Half of 2027

    Lunai Bioworks (Nasdaq: LNAI) Signs Definitive Collaboration Agreement with BrainStorm Therapeutics; Initial Parkinson's Disease Data Readout Targeted for First Half of 2027
    PR Newswire 2mo ago
    Lunai Bioworks (Nasdaq: LNAI) Names 10 Defendants in Naked Short Selling Fraud Suit

    Lunai Bioworks (Nasdaq: LNAI) Names 10 Defendants in Naked Short Selling Fraud Suit
    PR Newswire 2mo ago
    LUNAI BIOWORKS: CEO LETTER TO SHAREHOLDERS

    LUNAI BIOWORKS: CEO LETTER TO SHAREHOLDERS
    PR Newswire 4mo ago
    Lunai Bioworks Completes $20 Million Preferred Issuance to Acquire CNS Delivery and Neurotherapeutic IP

    Lunai Bioworks Completes $20 Million Preferred Issuance to Acquire CNS Delivery and Neurotherapeutic IP
    PR Newswire 5mo ago
    Lunai Bioworks (NASDAQ: LNAI) and Geneial Sign LOI to Build Rare Disease Patient Cohorts for Pharma Partnerships

    Lunai Bioworks (NASDAQ: LNAI) and Geneial Sign LOI to Build Rare Disease Patient Cohorts for Pharma Partnerships
    PR Newswire 6mo ago
    BC-Most Active Stocks

    BC-Most Active Stocks
    Associated Press Finance 7mo ago
    Lunai Bioworks: Fiscal Q2 Earnings Snapshot

    Lunai Bioworks: Fiscal Q2 Earnings Snapshot
    Associated Press Finance 8mo ago
    Oncotelic Therapeutics Announces Closing of a Strategic Monetization of Its CNS/Nasal Assets with Lunai Bioworks, Advancing Joint Development in Biodefense and Alzheimer’s Disease

    Oncotelic Therapeutics Announces Closing of a Strategic Monetization of Its CNS/Nasal Assets with Lunai Bioworks, Advancing Joint Development in Biodefense and Alzheimer’s Disease
    GlobeNewswire 5mo ago

    Related Tickers

    Mobilize your Website
    View Site in Mobile | Classic
    Share by: